跳至主要内容
临床试验/IRCT2015030918741N1
IRCT2015030918741N1已完成未知

Ascorbic acid effectiveness in prevention of contrast mediated nephropathy in patients underwent coronary angiography

Vice chancellor for research of Mazandaran University of Medical Sciences0 个研究点目标入组 320 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
320

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Inclusion Criteria: All the patients who underwent angiography and did not meet exclusion criteria
  • Exclusion criteria: End stage renal disease; creatinin above 3 or Glumerolar filtration rate below 30 ml/min; Administration of intra venues contrast media in last 6 days; use of ascorbic acid daily in last week before coronary angiography; sever hypertention ; severe heart failure (NYHA class 3-4)

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research of Mazandaran University of Medical Sciences

相似试验

Vitamin C effectiveness in prevention of contrast... | 临床试验